MedGenome

About:

MedGenome develops a genomics-based diagnostics and research solution for healthcare providers to understand the genetic basis of diseases.

Website: https://diagnostics.medgenome.com

Twitter/X: MedGenomeLabs

Top Investors: Sequoia Capital, LeapFrog Investments, Peak XV Partners, International Finance Corporation, Novo Holdings

Description:

MedGenome is a developer of sequencing genomics-based diagnostics and research platform intended to improve global health. The company's platform applies genomics technologies, bioinformatics, computing, and big data analytics to the genetically diverse and large population to understand the genetic basis of cancer, metabolic disorders, eye disorders, and other rare diseases, enabling the healthcare industry to develop deep insights into diseases at the genetic and molecular level.

Total Funding Amount:

$186M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Bangalore, Karnataka, India

Founded Date:

2013-01-01

Contact Email:

diagnostics(AT)medgenome.com

Founders:

Mahesh Pratapneni, Sam Santhosh

Number of Employees:

501-1000

Last Funding Date:

2022-08-30

IPO Status:

Private

Industries:

© 2025 bioDAO.ai